ENO1 and Patent ductus arteriosus: In particular, two out of six ENO isoforms (ENO1 and ENO2) were found to be preferentially expressed in PDA, and phosphorylated on serine 419, triggering a humoral response in more than half of PDA patients with a better clinical course and prognosis [90].